AI-DRIVEN PHARMACOLOGY: PREDICTING DRUG RESPONSES THROUGH INTELLIGENT MOLECULAR MODELING

Abstract

Artificial intelligence (AI) has emerged as a transformative force in pharmacology by enabling accurate prediction of drug responses through intelligent molecular modeling, computational toxicology, and precision medicine approaches. Traditional drug discovery and pharmacological evaluation are often constrained by high costs, prolonged timelines, low success rates, and complex biological variability. AI-driven pharmacology integrates machine learning, deep learning, neural networks, molecular docking, quantitative structure–activity relationship (QSAR) modeling, and systems biology to accelerate drug development and optimize therapeutic outcomes. Advanced computational models can predict pharmacokinetics, pharmacodynamics, toxicity, molecular interactions, adverse drug reactions, and individualized treatment responses with remarkable precision. AI-assisted molecular modeling facilitates rapid screening of millions of compounds, identification of novel therapeutic targets, and optimization of lead compounds while minimizing experimental burden. Furthermore, integration of genomic, proteomic, metabolomic, and clinical datasets has enabled personalized pharmacology tailored to individual patient characteristics. Recent developments in generative AI, explainable AI, digital twins, and reinforcement learning are revolutionizing intelligent drug design and therapeutic prediction systems. Despite these advances, significant challenges remain regarding data quality, algorithmic bias, interpretability, ethical concerns, cybersecurity, and regulatory standardization. AI-driven pharmacology also faces limitations related to biological complexity, heterogeneous datasets, and translational reliability. This article comprehensively examines the principles, methodologies, applications, challenges, ethical implications, and future prospects of AI-assisted molecular modeling in modern pharmacology. The convergence of artificial intelligence with pharmacological sciences holds extraordinary potential for reshaping precision therapeutics, improving patient safety, reducing drug development failures, and accelerating the discovery of next-generation medicines for complex human diseases.